# Bulk Manufacturer of Controlled Substances Application: S&B Pharma, Inc.; Correction
> **Notice** · Notice of application; correction. · Published 2020-03-10 · 85 FR 13931
## Document
- **Document number:** 2020-04829
- **Category:** application
- **Type:** Notice
- **Action:** Notice of application; correction.
- **Citation:** 85 FR 13931
- **Publication date:** 2020-03-10
- **Party named:** S&B Pharma, Inc.; Correction
## Abstract

The Drug Enforcement Administration (DEA) published a document in the Federal Register on November 22, 2019, concerning a notice of application. As that document correctly indicated, the applicant, S&B Pharma, Inc., DBA Norac Pharma, 405 South Motor Avenue, Azusa, California 91702-3232 applied to be registered as a bulk manufacturer of a number of controlled substances, to include applying for authorization in order to synthetically manufacture using drug code 7360 (marihuana). However, on the notice of application published, drug code 7360 was inadvertently identified and listed as Gamma Hydroxybutyric Acid instead of Marihuana.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2020/03/10/2020-04829/bulk-manufacturer-of-controlled-substances-application-sandb-pharma-inc-correction)
---
*AI Analytics · CC0 1.0*